Dr Ronwyn van Eeden helps us understand why people who never smoked get lung cancer.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Dr Ronwyn van Eeden helps us understand why people who never smoked get lung cancer.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Most people would be devastated to hear they have lung cancer, but once Christa Mather learnt that a targeted therapy offered new hope for people with the type of cancer she has, she simply put one foot in front of the other.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
After eight years of changing treatment regimens to manage Stage 4 lung cancer, Bessie van Antwerp happily reports a major tumour shrinkage thanks to the targeted drug, osimertinib.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Dr Thobile Goba-Mjwara describes the diagnostic journey of lung cancer and how new treatments and biomarker tests are leading the way to hope.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
 The Cancer Association of South Africa (CANSA) shares the most common questions that are asked regarding lung cancer.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Cancer affects one in four South Africans through diagnosis of family, friends, colleagues or self. In South Africa, lung cancer is the fifth most common cancer in women and the third most common cancer in men.1 Earlier detection of lung cancer is imperative to improve the survival rates of this disease.2
Oncology Buddies is proud to present the first Advanced NSCLC ALK+ lung cancer patient journey for your ease of reference and understanding of the route your journey may look like. Please note: this patient journey is only for ALK+ lung cancer and not applicable for all lung cancer patients.
